Free Trial

ACADIA Pharmaceuticals (ACAD) SEC Filings & 10K Form

ACADIA Pharmaceuticals logo
$14.58 +0.47 (+3.33%)
Closing price 04/11/2025 04:00 PM Eastern
Extended Trading
$14.58 0.00 (0.00%)
As of 04/11/2025 05:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent ACADIA Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/08/2025
6:38 PM
ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2025
6:40 PM
ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
6:52 PM
ACADIA Pharmaceuticals (Issuer)
Thompson Elizabeth H.Z. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
7:03 PM
ACADIA Pharmaceuticals (Issuer)
Rhodes Jennifer J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
7:06 PM
ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
7:10 PM
ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
6:49 PM
ACADIA Pharmaceuticals (Issuer)
Owen Adams Catherine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
5:30 PM
ACADIA Pharmaceuticals (Issuer)
GAROFALO ELIZABETH A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
11:17 AM
ACADIA Pharmaceuticals (Subject)
GAROFALO ELIZABETH A. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
4:26 PM
ACADIA Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2025
5:46 PM
ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
5:48 PM
ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
8:00 AM
ACADIA Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SCHEDULE 13G/A
02/07/2025
5:04 AM
ACADIA Pharmaceuticals (Subject)
BlackRock, Inc. (Filed by)
Form SCHEDULE 13G/A
12/11/2024
3:22 PM
ACADIA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2024
5:33 PM
ACADIA Pharmaceuticals (Issuer)
Garner Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
5:31 PM
ACADIA Pharmaceuticals (Issuer)
Garner Thomas (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/19/2024
7:40 PM
ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
7:41 PM
ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
7:43 PM
ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
5:48 AM
ACADIA Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
10/15/2024
5:05 PM
ACADIA Pharmaceuticals (Issuer)
Ndu Adora (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2024
5:46 PM
ACADIA Pharmaceuticals (Issuer)
Adams Catherine Owen (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/25/2024
5:53 PM
ACADIA Pharmaceuticals (Issuer)
Adams Catherine Owen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
4:14 PM
ACADIA Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/23/2024
3:34 PM
ACADIA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2024
5:40 PM
ACADIA Pharmaceuticals (Issuer)
DAVIS STEPHEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
5:43 PM
ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
5:46 PM
ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:37 PM
ACADIA Pharmaceuticals (Filer)
Form S-8 POS
08/20/2024
3:39 PM
ACADIA Pharmaceuticals (Filer)
Form S-8 POS
08/20/2024
3:23 PM
ACADIA Pharmaceuticals (Filer)
Form S-8 POS
08/20/2024
3:25 PM
ACADIA Pharmaceuticals (Filer)
Form S-8 POS
08/20/2024
3:27 PM
ACADIA Pharmaceuticals (Filer)
Form S-8 POS
08/20/2024
3:29 PM
ACADIA Pharmaceuticals (Filer)
Form S-8 POS
08/20/2024
3:31 PM
ACADIA Pharmaceuticals (Filer)
Form S-8 POS
08/20/2024
3:33 PM
ACADIA Pharmaceuticals (Filer)
Form S-8 POS
08/13/2024
5:05 PM
ACADIA Pharmaceuticals (Issuer)
Thompson Elizabeth H.Z. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:13 PM
ACADIA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Brege Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Now I look stupid. Real stupid... (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

05/31/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
SOLAND DANIEL B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
HARRIGAN EDMUND (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Daly James M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
GAROFALO ELIZABETH A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Ndu Adora (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:23 PM
ACADIA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2024
3:21 PM
ACADIA Pharmaceuticals (Filer)
Form DEF 14A
04/15/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Thompson Elizabeth H.Z. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:ACAD) was last updated on 4/12/2025 by MarketBeat.com Staff
From Our Partners